Skip to main content
Independent science journalism
We do not sell or supply peptides
Peptide
Science
Daily
News
Research
Compounds
Trials
Regulatory
Safety
Trackers
Search
⌘K
Subscribe
News
Research
Compounds
Trials
Regulatory
Safety
Trackers
Theme
Subscribe to the newsletter
We do not sell or supply peptides.
Home
Trials
NCT03226821
Clinical Trials · NCT03226821
Body Composition and Adipose Tissue in HIV
Terminated
Phase 4
Tesamorelin
(Prohibited)
Phase
Phase 4
Recruitment status
Terminated
Sponsor
Columbia University
Enrollment
6
Start date
Feb 2018
Locations
1 site, United States
Primary endpoint
Hepatic Lipid Content
View Tesamorelin compound reference